| Name | Title | Contact Details |
|---|---|---|
Jose Carmona |
Chief Financial Officer | Profile |
Theo Proukou |
Senior Vice President and Chief People Officer | Profile |
Jill Murray |
Director, Human Resource Business Partner and Interim Head of Total Rewards | Profile |
Torben Nissen |
Chief Executive Officer | Profile |
Clinical Data, Inc. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body`s immune system for the treatment of cancer. We are leveraging our proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Our INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Our most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors. We are continuing preclinical studies for both WTX-124 and WTX-330 and expect to advance each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor.
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. Forge has developed a fundamentally new approach for the discovery of metalloprotein inhibitors by focusing first on the metal in the enzyme active site.
Gliknik Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders.
MGI PHARMA, Inc. is a Lake Villa, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.